Bronchogenic Carcinoma — Trials

Bronchogenic Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

35 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Nanfang Hospital, Southern Medical University
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (7)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06494241	Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) Study	active not recruiting	—	1,000	AstraZenecaINDUSTRY	1	Sep 29, 2026	clinicaltrials
NCT06376084	Osimertinib With Chemotherapy as First-line Therapy for EGFR Mutation-positive NSCLC(FOREFRONT)	active not recruiting	—	532	AstraZenecaINDUSTRY	1	Aug 18, 2026